← All trials
NCT04566510
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 17, 2020
- Primary completion
- Apr 15, 2023
- Completion date
- Apr 15, 2023
- First posted
- Sep 28, 2020
- Last posted
- Dec 17, 2020
- Enrollment
- 200000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, San FranciscoLead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- University of LondonOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.